Results 31 to 40 of about 252 (105)

Efficacy and Safety of MLC601 (NeuroAiD®), a Traditional Chinese Medicine, in Poststroke Recovery: A Systematic Review [PDF]

Cerebrovascular Diseases, 2013
<b><i>Background:</i></b> Subsequent to a pooled analysis of 2 trials, several more studies have been published assessing the benefit of MLC601 in stroke patients. Hence, it is timely to conduct an updated meta-analysis to frame the interpretation of the results of an ongoing large multicenter, randomized, double-blind, placebo ...
Fahad Javaid, Siddiqui, Narayanaswamy, Venketasubramanian, Edwin Shih-Yen, Chan, Christopher, Chen   +3 more
openaire   +2 more sources

Vascular dementia: neurological assessment and cardiovascular manifestations [PDF]

, 2023
Vascular dementia is a form of dementia caused by brain damage resulting from problems with blood flow to the brain. It is often associated with risk factors and cardiovascular manifestations, such as high blood pressure, diabetes mellitus, ischemic ...
Binsfeld, Willimar Gleiser Schmidt, Carvalho, Gilson Gabriel Coutinho, Fogolin, Vittoria Teixeira, Fontana, Luiza Lubiana, Fortunati, Lorenza Alves de Carvalho, Godinho, Raissa de Kássia Aparecida Fernandes, Honorato, Jordana de Castro, Martins, Laura Faria, Melo, Caio Viçoso Vaz de, Rezende, Larissa Cardoso, Saiki, Rafael Yuri Almeida, Silva, Vitor Freitas da   +11 more
core   +2 more sources

Predictors of Neurological and Functional Recovery in Patients with Moderate to Severe Ischemic Stroke: The EPICA Study

Stroke Research and Treatment, Volume 2020, Issue 1, 2020., 2020
Background. Improving our knowledge about the impact of restorative therapies employed in the rehabilitation of a stroke patient may help guide practitioners in prescribing treatment regimen that may lead to better post‐stroke recovery and quality of life. Aims.
Manuel Murie-Fernández, Mercedes Molleda Marzo, Raymond T. Cheung   +2 more
wiley   +1 more source

Herbs and Rehabilitation after Stroke Study: A Multi-center, Double-blinded, Randomized Trial in Hong Kong [PDF]

, 2016
published_or_final_versio
Chang, CM, Chang, SKR, Cheung, RTF, Chook, P, Lau, KK, Leung, PC, Leung, T, Li, R, Li, T, Mok, M, Mok, V, Pang, SYY, Sheung, B, Tse, CTA, Tsoi, TH, Wong, KS, Xiong, L, Yeung, J   +17 more
core   +1 more source

Targeting neurogenesis: a promising therapeutic strategy for post-stroke treatment with Chinese herbal medicine [PDF]

, 2014
published_or_final_versio
Chen, X, Chen, X, Deng, R, Shen, J
core   +1 more source

Frequency and Clinical Impact of Serious Adverse Events on Post-Stroke Recovery with NeuroAiD (MLC601) versus Placebo: The CHInese Medicine Neuroaid Efficacy on Stroke Recovery Study [PDF]

Cerebrovascular Diseases, 2020
<b><i>Background:</i></b> Most comparative clinical trials are designed to assess the treatment effect for efficacy endpoints, with less emphasis on the analysis of safety outcomes. However, an extensive analysis of safety data could demonstrate beneficial results in terms of effectiveness by reducing serious adverse events ...
Narayanaswamy, Venketasubramanian, Rajesh B, Moorakonda, Qingshu, Lu, Christopher L H, Chen   +3 more
openaire   +2 more sources

CHInese medicine NeuroAiD efficacy on stroke recovery - Extension study (CHIMES-E): A multicenter study of long-term efficacy [PDF]

, 2015
© 2015 S. Karger AG, Basel. Background: The CHInese Medicine NeuroAiD Efficacy on Stroke recovery (CHIMES) study was an international randomized double-blind placebo-controlled trial of MLC601 (NeuroAiD) in subjects with cerebral infarction of ...
Alejandro C. Baroque II, Annabelle Y. Lao, Bernard P.L. Chan, Carlos L. Chua, Christopher L.H. Chen, Chun Fan Lee, Gaik Bee Eow, H. Asita de Silva, Herminigildo H. Gan, Hui Meng Chang, Joel M. Advincula, John Harold B. Hiyadan, Jose C. Navarro, K.S. Lawrence Wong, Narayanaswamy Venketasubramanian, Nijasri C. Suwanwela, Niphon Poungvarin, Nirmala Wijekoon, null null, San San Tay, Sherry H. Young, Sombat Muengtaweepongsa, Thirugnanam Umapathi   +22 more
core   +1 more source

Organizational factors determining access to reperfusion therapies in Ischemic Stroke-Systematic literature review [PDF]

, 2022
Background: After onset of acute ischemic stroke (AIS), there is a limited time window for delivering acute reperfusion therapies (ART) aiming to restore normal brain circulation. Despite its unequivocal benefits, the proportion of AIS patients receiving
Botelho, Ana, Ferreira, Eugénia, Fidalgo, Ana Paula, Nzwalo, Hipólito, Rios, Jonathan   +4 more
core   +2 more sources

Efficacy and Tolerability of MlC601 in Patients with Mild to Moderate Alzheimer Disease who were Unable to Tolerate or Failed to Benefit from Treatment with Rivastigmine [PDF]

British Journal of Medicine and Medical Research, 2013
Aim: To evaluate the efficacy and tolerability of MLC601 in patients with mild to moderate Alzheimer disease (AD). Study Design: This is an open-label pilot study. Place and Duration of Study: It was conducted at three university referral centres in Iran from September 2009 until November 2011.
Harandi, Ali Amini, Ashrafi, Farzad, Tabatabaei, Mojgan, Ghorbani, Askar, Hatamian, Hamid Reza, Pakdaman, Hossein, Ilkhani, Manochehr, Gharagozli, Koroush, Shojae, Maziar, Asadollahi, Marjan, Alaeddini, Farshid, Hosseini, Seyed Kazem   +11 more
openaire   +2 more sources

Developing Traditional Chinese Medicine in the Era of Evidence‐Based Medicine: Current Evidences and Challenges

Evidence-Based Complementary and Alternative Medicine, Volume 2015, Issue 1, 2015., 2015
Evidence‐based medicine (EBM), by integrating individual clinical expertise with the best available clinical evidence from systematic research, has in recent years been established as the standard of modern medical practice for greater treatment efficacy and safety.
Foon Yin Fung, Yeh Ching Linn, Felice Senatore   +2 more
wiley   +1 more source